A new series of 2- and/or 3-substituted pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides and their 8-chloro derivatives were synthesized, and their benzodiazepine receptor (BZR) affinities were evaluated in vitro in comparison to lead compound 3-ethoxycarbonyl-8-chloropyrazolo[5,1-c][1,2,4]benzotriazine-5-oxide (29) [1,2]. None of the new compounds showed significant affinity for BZR. On the basis of a pharmacophore/receptor model suggested for lead compound 29, some hypotheses to explain the inactivity of new derivatives are discussed. (C) 1999 Elsevier Science S.A. All rights reserved.
EICKEN, K.;SCHEIB, K.;THEOBALD, H.;POMMER, E. -H.;AMMERMANN, E.
作者:EICKEN, K.、SCHEIB, K.、THEOBALD, H.、POMMER, E. -H.、AMMERMANN, E.
DOI:——
日期:——
JPS562902A
申请人:——
公开号:JPS562902A
公开(公告)日:1981-01-13
Investigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens
作者:Jennifer I. Brown、Rosanne Persaud、Petar Iliev、Ujjwala Karmacharya、Sanaz Attarha、Henok Sahile、Jonas E. Olsen、Danielle Hanke、Temilolu Idowu、David A. Frank、Adam Frankel、Karla C. Williams、Brent D.G. Page